Whether or not the United States has safe and effective medical countermeasures--such as vaccines, drugs, and diagnostic tools--available for use during a disaster can mean the difference between life and death for many Americans. The Food and Drug Administration (FDA) and the scientific community at large could benefit from improved scientific tools and analytic techniques to undertake the complex scientific evaluation and decision making needed to make essential medical countermeasures available. At the request of FDA, ...

Advancing Regulatory Science for Medical Countermeasure Development: Workshop Summary 2011, National Academies Press, Washington

ISBN-13: 9780309214902

Paperback

Select